EUVIMEDEUVIMED entdecken
Crossref

DTI-ALPS index-assessed glymphatic dysfunction mediates Alzheimer’s cognitive decline via amyloid-β-dependent pathways: multimodal PET/MRI study

Yan Zhang, Gan Huang, Jieli Geng, Xia Li, Mei Xin, Peizhe Yuan, Yue Wang, Qun Xu, Gang Wang, Gang Huang, Jianjun Liu, Chenpeng Zhang iD

European Journal of Nuclear Medicine and Molecular Imaging · 2025-12 · 53 (1) · 467-479

DOI: 10.1007/s00259-025-07445-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 18.07.2025. Verfasst von Yan Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, …. Hauptthemen laut MEDLINE: Alzheimer Disease, Positron-Emission Tomography, Glymphatic System, Amyloid beta-Peptides. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: the construction project of Shanghai Key Laboratory of Molecular Imaging, Shanghai ageing women and children's health research program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The role of glymphatic dysfunction in Alzheimer's disease (AD), as measured by diffusion tensor imaging along perivascular spaces (DTI-ALPS) indexing of perivascular function, its progression, and its interaction with amyloid-β (Aβ) and tau proteins, remains controversial. To investigate whether the DTI-ALPS index mediates AD-related cognitive decline through Aβ/tau-dependent pathways using tri-tracer PET/MRI. METHODS: This retrospective study (2021-2024) analyzed 140 participants (median age 69.00 [61.00, 74.00] years; 84 women), including 99 with AD (37 early-onset [EOAD], 62 late-onset [LOAD]), 35 with mild cognitive impairment (MCI), and 6 with subjective cognitive decline (SCD). All participants underwent simultaneous [1⁸F] Florbetapir (Aβ), [1⁸F] PI-2620(tau), and [1⁸F] FDG PET/MRI with DTI-ALPS indexing for glymphatic function quantification. Causal mediation analysis was used to assess the relationships between biomarkers (P 0.05). The Aβ-negative subgroups showed correlations with ALPS-age (r = - 0.48, P = 0.007), ALPS-education (r = 0.39, P = 0.035), and ALPS-cognition (MoCA: r = 0.62, P < 0.001). The Aβ-positive subgroups revealed inverse ALPS-Aβ associations (ρ = - 0.27, P = 0.010; age/education-adjusted ρ = - 0.24, P = 0.022) alongside positive adjusted correlations with cognition (MMSE: ρ = 0.28, P = 0.009). EOAD exhibited distinct ALPS-cognition relationships compared to LOAD (MMSE: r = - 0.39, P = 0.016 vs. ρ = - 0.06, P = 0.620). CONCLUSION: DTI-ALPS quantifies glymphatic dysfunction driving AD progression predominantly through Aβ-dependent pathways, with EOAD demonstrating distinct neuroimaging-cognition relationships compared to LOAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseasePositron-Emission TomographyGlymphatic SystemAmyloid beta-PeptidesDiffusion Tensor ImagingCognitive DysfunctionMultimodal ImagingMagnetic Resonance ImagingHumansFemaleMaleAgedMiddle AgedRetrospective StudiesAged, 80 and overtau Proteins

Stichwörter der Autor:innen

ALPSAlzheimer's diseaseAmyloidFDGPositron emission tomographyTau

Substanzen

Amyloid beta-Peptidestau Proteins

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
  • Department of Neurology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Alzheimer's Disease and Related Disorders Center, Shanghai Jiao Tong University, National Center for Mental Disorders, Shanghai, China.
  • Health Manage Center, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China.

ORCID-Profile: Chenpeng Zhang

Förderung

  • the construction project of Shanghai Key Laboratory of Molecular Imaging
  • Shanghai ageing women and children's health research program

Zitieren

APA

Zhang, Y., Huang, G., Geng, J., Li, X., Xin, M., Yuan, P., Wang, Y., Xu, Q., Wang, G., Huang, G., Liu, J., & Zhang, C. (2025). DTI-ALPS index-assessed glymphatic dysfunction mediates Alzheimer’s cognitive decline via amyloid-β-dependent pathways: multimodal PET/MRI study. European Journal of Nuclear Medicine and Molecular Imaging, 53(1), 467-479. https://doi.org/10.1007/s00259-025-07445-2

Vancouver

Zhang Y, Huang G, Geng J, Li X, Xin M, Yuan P, et al. DTI-ALPS index-assessed glymphatic dysfunction mediates Alzheimer’s cognitive decline via amyloid-β-dependent pathways: multimodal PET/MRI study. European Journal of Nuclear Medicine and Molecular Imaging. 2025;53(1):467-479. doi:10.1007/s00259-025-07445-2

BibTeX
@article{Zhang2025,
  author = {Zhang, Yan and Huang, Gan and Geng, Jieli and Li, Xia and Xin, Mei and Yuan, Peizhe and Wang, Yue and Xu, Qun and Wang, Gang and Huang, Gang and Liu, Jianjun and Zhang, Chenpeng},
  title = {DTI-ALPS index-assessed glymphatic dysfunction mediates Alzheimer’s cognitive decline via amyloid-β-dependent pathways: multimodal PET/MRI study},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2025},
  volume = {53},
  number = {1},
  pages = {467--479},
  doi = {10.1007/s00259-025-07445-2}
}
Kostenlos starten →